TY - JOUR
T1 - Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond
AU - Hogarth, Phillip Mark
AU - Pietersz, Geoffrey A
PY - 2012
Y1 - 2012
N2 - This Review addresses various strategies to manipulate FcR function to overcome immune complex-mediated inflammatory diseases,
and considers approaches to improve antibody-based anticancer therapies.
AB - This Review addresses various strategies to manipulate FcR function to overcome immune complex-mediated inflammatory diseases,
and considers approaches to improve antibody-based anticancer therapies.
UR - http://www.nature.com/nrd/journal/v11/n4/pdf/nrd2909.pdf
U2 - 10.1038/nrd2909
DO - 10.1038/nrd2909
M3 - Article
VL - 11
SP - 311
EP - 331
JO - Nature Reviews Drug Discovery
JF - Nature Reviews Drug Discovery
SN - 1474-1776
IS - 4
ER -
